10-K: Limitless X Holdings Faces Financial Challenges in 2025
Annual Report
Limitless X Holdings Inc. reported a significant net loss of $46.1 million for the fiscal year ended December 31, 2025, with substantial operating expenses and a going concern uncertainty noted by auditors.
Summary
- Limitless X Holdings Inc. reported a net loss of $46.1 million for the fiscal year ended December 31, 2025, a substantial increase from the $4.2 million loss in the prior year.
- Revenue decreased by 71.8% to $0.9 million in 2025 from $3.4 million in 2024, primarily due to a shift in marketing strategy from affiliate to in-house digital marketing.
- Operating expenses increased by 60.1% to $9.8 million in 2025, largely driven by a significant rise in stock compensation expense ($5.3 million).
- The company has a history of operating losses and an accumulated deficit of $84.9 million as of December 31, 2025.
- The independent auditor's report includes a going concern uncertainty paragraph, highlighting the company's reliance on future financing.
- The company is expanding into new sectors including film and television, regenerative skin care, fintech, entertainment, and real estate.
- Several legal proceedings and settlement agreements were noted, with a total loss on settlement of $35.5 million recorded in 2025.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this filing negatively due to the significant increase in net loss, substantial revenue decline, and the auditor's going concern warning, indicating considerable financial distress and operational challenges.
Positives
- Gross profit margin improved to 75.3% in 2025 from 67.0% in 2024, despite lower revenue, indicating better cost management on sold products.
- The company is actively pursuing diversification into new business areas such as film, entertainment, and technology.
- Strategic partnerships with influential figures like Manny Pacquiao and DJ Pauly D are in place to leverage their global visibility.
- The company has a clear strategy to integrate its subsidiaries to create a diversified ecosystem across health, wellness, entertainment, and media.
- New initiatives include the acquisition of a controlling interest in DING, a food and nutrition technology platform, to enhance data-driven meal planning and commerce capabilities.
Negatives
- Significant net loss of $46.1 million for the year ended December 31, 2025.
- Revenue decline of 71.8% to $0.9 million in 2025.
- Increase in operating expenses by 60.1% to $9.8 million, driven by stock compensation.
- Accumulated deficit of $84.9 million as of December 31, 2025.
- Auditor's report includes a going concern uncertainty paragraph.
- Material weaknesses in internal control over financial reporting were identified, including lack of a functioning audit committee and inadequate segregation of duties.
- Significant losses on debt settlement and legal settlements were recorded in 2025.
Risks
- The company has incurred significant losses and expects to continue incurring losses, with no certainty of achieving profitability.
- The independent auditor's report includes a going concern uncertainty paragraph.
- All current brands and products are licensed from an entity owned by the CEO, posing a risk of business loss if the agreement is terminated.
- Failure to cost-effectively acquire or retain customers could adversely affect the business.
- Reliance on social media and influencers carries reputational risks and potential for fines or penalties.
- The company relies on third-party vendors for essential business operations, and disruptions could impact service delivery.
- Shipping is critical, and changes or interruptions in shipping arrangements could adversely affect operating results.
- Increases in labor costs, including wages, could negatively impact the business.
- Failure to maintain and enhance brand awareness could adversely affect business and financial results.
- Potential liability for information displayed on e-commerce and other websites.
- Advertising inaccuracies or product mislabeling could lead to lawsuits, recalls, or regulatory actions.
- The company is subject to numerous other laws and regulations that could impact its business.
- Future financial performance depends on the ability to manage growth effectively.
- The company's securities are considered penny stock, which may discourage broker-dealer transactions.
- The company has identified material weaknesses in internal control over financial reporting.
- The company's stock price may be volatile due to limited public market and other factors.
- There is a limited public market for the common stock, and no assurance of an active or sustained trading market.
- The company's charter and bylaws may make acquisitions more difficult.
- Cybersecurity threats pose risks to sensitive information and operations.
Future Outlook
The company expects to continue incurring significant expenses and operating losses as it expands into new business areas. It anticipates needing to raise additional capital through equity financing or private placements to fund future operations. The company's ability to continue as a going concern is dependent on successful capital raising efforts.
Management Comments
- Jaspreet Mathur, CEO: 'When people are empowered with the right products, systems, and relationships, there are no limits to what they can achieve.'
- Jaspreet Mathur, CEO: 'Our business model is designed to allow its subsidiaries to support one another through shared customer relationships, marketing resources, and brand visibility.'
- Daniel Sanders, President: 'Mr. Sanders' background significantly strengthens the Company's ability to transition from high-margin direct-to-consumer success into large-scale retail, international expansion, and institutional-grade supply chain execution, materially reducing execution risk while expanding the Company's addressable market.'
Industry Context
StockSavvy.ai notes that Limitless X Holdings operates in the highly competitive global health and wellness market, which is projected to reach $9-10 trillion by 2029-2030. The company's integrated, omnichannel approach aims to capture market share by combining digital engagement with offline distribution and experiential access, aligning with industry trends towards personalization and digital health technologies.
Comparison to Industry Standards
- The company's revenue of $0.9 million for 2025 is significantly lower than industry leaders in the health and wellness sector, which often report revenues in the hundreds of millions or billions.
- The reported net loss of $46.1 million and accumulated deficit of $84.9 million indicate a substantial gap in profitability compared to established, profitable companies in the consumer packaged goods and wellness industries.
- The company's gross margin of 75.3% is strong, but this is overshadowed by high operating expenses, particularly stock compensation, which is not typical for mature companies in the sector.
- The reliance on related-party transactions for significant funding and operational agreements is a deviation from the standard practices of publicly traded companies aiming for independent governance and arms-length dealings.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Audit Committee Creation | On January 24, 2025, the board of directors authorized the creation of an Audit Committee. | 2025-01-24 | Enhances oversight of financial reporting and internal controls. |
| Compensation Committee Creation | On January 24, 2025, the board of directors authorized the creation of a Compensation Committee. | 2025-01-24 | Provides oversight of executive compensation policies. |
| Nominating Committee Creation | On January 24, 2025, the board of directors authorized the creation of a Nominating Committee. | 2025-01-24 | Oversees director nominations and corporate governance guidelines. |
| Director Appointment | Arthur Sarkissian was elected to the board of directors, effective January 1, 2025. | 2025-01-01 | Adds industry experience to the board. |
| President Appointment | Daniel C. Sanders was appointed President, effective January 5, 2026. | 2026-01-05 | Strengthens leadership in product development and manufacturing operations. |
Legal Proceedings
- Mentom Eyewear Inc. case dismissed with prejudice on May 28, 2024.
- Harpo Inc. case settled for $275,000, with $68,500 paid in 2025.
- Stubbs Alderton LLP matter resulted in a judgment for $40,000.
- Lace Marketing LLC case dismissed in January 2025.
- FKBR LLP matter resolved by a confidential settlement agreement, with final payment due May 4, 2026.
- Reid Granados case: Company has not yet been formally served; believes it will be dismissed.
- Blaker demand letter regarding CIPA violation settled for $11,000, not yet paid.
- Argyle Payments LLC case settled for $200,000, pending dismissal upon payment.
Related Party Transactions
- Settlement agreements with CEO Jaspreet Mathur, former President Kenneth Haller, and VP of Legal Affairs Rob Cucher for accrued compensation in 2024 and 2025, involving issuance of common stock.
- Dividend waiver agreements signed by CEO Jaspreet Mathur and entities controlled by him (Emblaze, EM1) for Series D Preferred Stock dividends totaling $539,444.
- License agreements with Limitless Performance Inc. (LPI), SMILZ INC., DIVATRIM INC., and AMAROSE INC. (companies owned by CEO Jas Mathur or entities he controls) for royalty payments.
- LPI waived all royalty payments for NZT-48 related products for three years ending December 31, 2027.
- Notes payable to shareholder Jaspreet Mathur totaling $5,144,460 as of December 31, 2024, which were converted to preferred stock in 2025.
- Notes payable to related parties (EM1 Capital LLC, Emblaze One) totaling $436,747 as of December 31, 2024, converted to preferred stock in 2025.
- Loan of $1 million from EM1 Capital LLC to Limitless Films, Inc. at 5% interest, maturing January 22, 2026.
- Promissory notes from Jaspreet Mathur and EM1 Capital LLC for working capital, with consideration including common stock and preferred stock.
- Debt conversion transactions with Jaspreet Mathur to settle outstanding debt, resulting in the issuance of Class C and Series D Preferred Stock.
- Exchange Agreements with EM1, Amarose, and LPI to exchange Class C Convertible Preferred Stock for Series D Preferred Stock.
- Binding Letter of Intent to acquire 60% of Ding Easy AI, LLC, a company wholly owned by President Daniel Sanders, for $9 million in common stock and growth capital.
Stakeholder Impact
- Shareholders: Potential dilution from future stock issuances, volatility in stock price, and concerns regarding internal controls and going concern status.
- Employees: Executive officers received significant portions of their salaries in stock, and stock options/awards were granted.
- Creditors: The company has a history of operating losses and an accumulated deficit, raising concerns about its ability to meet financial obligations.
- Suppliers: The company relies on third-party contract manufacturers and suppliers, and disruptions could impact product availability and costs.
Next Steps
- Continue to monitor the company's ability to secure additional capital.
- Observe the impact of the shift to in-house digital marketing on customer acquisition and revenue.
- Track the development and integration of new business ventures in film, entertainment, and technology.
- Assess the effectiveness of the company's efforts to remediate material weaknesses in internal controls.
- Evaluate the outcome of ongoing legal proceedings and settlement agreements.
Key Dates
| Date | Description |
|---|---|
| 2021-12-01 | Manufacturing & Distributorship License Agreement between Limitless X Inc. and Limitless Performance Inc. |
| 2022-05-11 | Share Exchange Agreement among Bio Lab Naturals, Inc., Limitless X, Inc., and Certain Shareholders. |
| 2022-05-20 | Completion and closing of the Limitless X Acquisition. |
| 2022-06-10 | Bio Lab changed its name to Limitless X Holdings Inc. |
| 2023-10-01 | Termination of License Agreements with Smilz, Divatrim, and Amarose. |
| 2023-11-01 | Amendment to LPI License Agreement for NZT-48. |
| 2024-01-24 | First Amendment to Manufacturing and Distributorship Agreement. |
| 2024-05-09 | Dismissal of BF Borgers CPA PC as independent registered public accounting firm and engagement of M&K CPAS, PLLC. |
| 2024-09-10 | Settlement Agreements and Release of Claims with Jaspreet Mathur, Kenneth Haller, and Rob D. Cucher for accrued compensation. |
| 2024-10-15 | Retail Lease by and between RWBP Highland, L.P. and Limitless Entertainment Group Inc. |
| 2024-12-10 | Promissory Note dated December 10, 2024 made by Limitless X Holdings, Inc. and Jaspreet Mathur. |
| 2024-12-31 | Year-end financial reporting date. |
| 2025-01-01 | Company plans to make a significant impact in television and film, regenerative skin care, fintech, entertainment and real estate. |
| 2025-01-05 | Daniel C. Sanders appointed President. |
| 2025-01-09 | Amended and Restated Certificate of Designation of Class C Convertible Preferred Stock filed. |
| 2025-01-13 | Settlement Agreements and Release of Claims with Jaspreet Mathur, Rob D. Cucher, Danielle Young, and Benjamin Chung for accrued compensation. |
| 2025-01-15 | Amended and Restated Certificate of Designation of Class C Convertible Preferred Stock filed. |
| 2025-01-22 | Promissory Note by and between the Company and CFI Capital, LLC. |
| 2025-01-23 | Certificate of Designation of Series D 15% Cumulative Redeemable Perpetual Preferred Stock filed. |
| 2025-01-26 | Binding Letter of Intent by and among Bodycor, Inc., the Company, and Ding Easy AI, LLC. |
| 2025-01-27 | Certificate of Designation of Series D 15% Cumulative Redeemable Perpetual Preferred Stock filed. |
| 2025-01-29 | Board approved stock option grants and restricted stock awards to executive officers and directors. |
| 2025-02-05 | Company had 1,046,836 shares issuable related to accrued salaries settlement, which were issued. |
| 2025-02-05 | Company had 250,000 shares issuable related to executive compensation, which were issued. |
| 2025-02-07 | Debt conversion transaction with Jaspreet Mathur to settle outstanding debt. |
| 2025-02-09 | Binding Letter of Intent by and among Bodycor, Inc., the Company, and Ding Easy AI, LLC filed. |
| 2025-02-10 | Company had 34,649 shares issuable related to consulting services, which were issued. |
| 2025-02-11 | Promissory Note dated February 11, 2022 between Limitless X, Inc. and Jaspreet Mathur. |
| 2025-02-14 | Amended and Restated Bylaws filed. |
| 2025-02-14 | 2022 Restricted Stock Plan filed. |
| 2025-02-14 | 2022 Stock Option Plan filed. |
| 2025-02-14 | Amended Certificate of Designation of Class B Preferred Convertible Stock filed. |
| 2025-02-14 | Amended and Restated Certificate of Incorporation filed. |
| 2025-02-27 | Exchange Agreements by and between the Company and EM1 Capital, LLC filed. |
| 2025-03-21 | Promissory Note dated March 21, 2025 by and between Limitless X Holdings, Inc. and Jaspreet Mathur filed. |
| 2025-03-24 | Promissory Note by and between the Company and Emblaze One, a company owned by the shareholder. |
| 2025-03-25 | Promissory Note dated March 21, 2025 by and between Limitless X Holdings, Inc. and Jaspreet Mathur filed. |
| 2025-04-10 | Company issued 10,000 preferred C shares and 225,000 common stock shares under loan agreement. |
| 2025-04-14 | Debt conversion agreements with Jaspreet Mathur and EM1 Capital, LLC and Emblaze One, LLC. |
| 2025-04-16 | Vendor Debt Conversion Agreement dated April 14, 2025 by and Between Limitless X Holdings, Inc. and Jaspreet Mathur filed. |
| 2025-04-16 | Vendor Debt Conversion Agreement dated April 14, 2025 by and Between Limitless X Holdings, Inc. and EM1 Capital LLC filed. |
| 2025-04-16 | Vendor Debt Conversion Agreement dated April 14, 2025 by and Between Limitless X Holdings, Inc. and Emblaze One, Inc. filed. |
| 2025-05-20 | Second Amendment to Manufacturing and Distributorship Agreement dated May 20, 2025 filed. |
| 2025-05-29 | Addendum to Bridge Loan Agreement dated as of May 29, 2025 between Limitless X Holdings, Gentlemen Thief, LLC and Randall Emmett filed. |
| 2025-06-09 | Promissory Note (and First Amendment) by and between Limitless X Holdings Inc. and EM1 Capital LLC dated June 9, 2025 filed. |
| 2025-06-13 | Promissory Note (and First Amendment) by and between Limitless X Holdings Inc. and EM1 Capital LLC filed. |
| 2025-06-13 | Promissory Note by and between Limitless X Holdings Inc. and EM1 Capital LLC dated June 11, 2025 filed. |
| 2025-06-30 | Second Amendment to Promissory Note by and between Limitless X Holdings Inc. and EM1 Capital LLC filed. |
| 2025-07-11 | Promissory Note dated July 11, 2025 by and between Limitless X Holdings Inc. and EM1 Capital LLC filed. |
| 2025-07-11 | Warrant Agreement dated July 11, 2025 by and between Limitless X Holdings Inc. and EM1 Capital LLC filed. |
| 2025-07-14 | Class C Convertible shareholder converted 7,400 Class C Convertible stock to common shares. |
| 2025-07-14 | Warrant Agreement dated July 11, 2025 by and between Limitless X Holdings Inc. and EM1 Capital LLC filed. |
| 2025-09-15 | Second Addendum to Bridge Loan Agreement by and among Limitless Films, Inc., Gentleman Thief LLC, and Randall Emmett. |
| 2025-09-30 | Company entered into an accrued dividend waiver agreement with CEO. |
| 2025-09-30 | Company entered into a settlement agreement with Mr. Mathur, Mr. Chung, Mr. Cucher and Ms. Young for accrued salaries. |
| 2025-11-03 | Securities Purchase Agreement by and between the Company and CFI Capital, LLC dated November 3, 2025 filed. |
| 2025-11-05 | Securities Purchase Agreement by and between the Company and Labrys Fund II, L.P. dated November 5, 2025 filed. |
| 2025-11-10 | Securities Purchase Agreement by and between the Company and GS Capital Partners, LLC dated November 10, 2025 filed. |
| 2025-11-11 | Promissory Note Agreement by and between the Company and Auctus Fund, LLC dated November 11, 2025 filed. |
| 2025-11-11 | First Warrant by and between the Company and Auctus Fund, LLC dated November 11, 2025 filed. |
| 2025-11-11 | Second Warrant by and between the Company and Auctus Fund, LLC dated November 11, 2025 filed. |
| 2025-11-11 | Securities Purchase Agreement by and between the Company and Auctus Fund, LLC dated November 11, 2025 filed. |
| 2025-11-20 | Third Amendment to Manufacturing and Distribution Licensing Agreement effective as of September 30, 2025 filed. |
| 2025-11-20 | Form of Dividend Waiver Agreement, effective as of September 30, 2025 filed. |
| 2025-12-31 | Year-end financial reporting date. |
| 2026-01-01 | Company purchased 80% interest of Limitless Films, Inc. and Limitless Entertainment Group, Inc. |
| 2026-01-26 | Retail Lease by and between RWBP Highland, L.P. and Limitless Entertainment Group Inc. dated October 15, 2025 filed. |
| 2026-01-26 | Promissory Note by and between the Company and CFI Capital, LLC dated November 3, 2025 filed. |
| 2026-01-26 | Promissory Note Agreement by and between the Company and Labrys Fund II, L.P. dated November 5, 2025 filed. |
| 2026-01-26 | Promissory Note by and between the Company and GS Capital Partners, LLC dated November 10, 2025 filed. |
| 2026-01-26 | Promissory Note Agreement by and between the Company and Auctus Fund, LLC dated November 11, 2025 filed. |
| 2026-01-26 | Guaranty Agreement made by Limitless X Holdings Inc. and Jas Mathur in favor of RWBP Highland, L.P. dated October 15, 2025 filed. |
| 2026-02-05 | Company issued shares for accrued salaries settlement and executive compensation. |
| 2026-02-09 | Binding Letter of Intent by and among Bodycor, Inc., the Company, and Ding Easy AI, LLC filed. |
| 2026-02-10 | Company issued shares for consulting services. |
| 2026-02-27 | Exchange Agreements by and between the Company and AMAROSE INC. filed. |
| 2026-02-27 | Exchange Agreements by and between the Company and Limitless Performance, Inc. filed. |
| 2026-02-27 | Exchange Agreements by and between the Company and EM1 Capital, LLC filed. |
| 2026-04-15 | Date of report signing. |
Recommendation
sellThe company exhibits significant financial distress with a substantial increase in net loss, a sharp decline in revenue, and a going concern warning from its auditor. The identified material weaknesses in internal controls and heavy reliance on related-party transactions further increase the risk profile. While diversification efforts are noted, the current financial performance and operational challenges suggest a high risk for investors.
Keywords
Limitless X Holdings, SEC Filing, Form 10-K, Annual Report, Financial Results, Net Loss, Operating Expenses, Going Concern, Stock Compensation, Brand Development, Health and Wellness, Film and Entertainment, Digital Marketing, Related Party Transactions, Debt Settlement, Legal Proceedings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.